NCT01879709

Brief Summary

Cognitive impairment is a key disabling feature of SZ. The impairment affects functional outcome and employability, resulting in increased burden. Currently, medications offer only modest benefits for the cognitive dysfunction. Hence, non-pharmacological interventions are worth consideration. Yoga is known to enhance cognitive abilities in healthy persons. Our preliminary studies have shown for the first time that there may be remarkable improvement in selected cognitive domains among outpatients with SZ. The improvement is unlikely to be due to rater bias, as they were noted using a computerized neurocognitive battery. Since our preliminary studies involved an open trial, it is necessary to conduct more controlled studies. To evaluate our results further, we propose to test the effectiveness of yoga supplementation using a controlled single blind design in India. Outpatients with SZ (N=258) undergoing treatment at a large academic center in New Delhi, India will be randomly assigned to one of the three groups- yoga training (YT, N=86), physical exercise (PE, N=86) or treatment as usual (TAU, N=86). The YT group will undergo 21 days yoga supplementation, while the PE group will complete a 21 day systematic physical exercise training regime. The third group will have no such supplementation. Cognitive state, symptom severity and overall function will be assessed at four time points: just before, immediately after, three months later and six months after completion of YT/PE supplementation. The evaluations will be conducted by raters blind to group status. Hypotheses:

  1. 1.Yoga enhances attention, as well as related cognitive function among persons with schizophrenia.
  2. 2.Yoga has beneficial effects on the short term functional outcome of schizophrenia

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
286

participants targeted

Target at P75+ for not_applicable schizophrenia

Timeline
Completed

Started Aug 2010

Longer than P75 for not_applicable schizophrenia

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

June 13, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 18, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

November 29, 2016

Status Verified

November 1, 2016

Enrollment Period

5.1 years

First QC Date

June 13, 2013

Last Update Submit

November 28, 2016

Conditions

Keywords

schizophreniaCognitionIndependent living skills

Outcome Measures

Primary Outcomes (1)

  • Cognitive assessment

    The key assessment will be based on an efficient, validated computerized battery called the Computerized Neurocognitive Battery (CNB) {Gur, 2001 #38} {Gur, 2001} . The assessment will be supplemented by the Information subscale of Post-graduate Institute Battery of Brain Dysfunction (PGI) (as an indirect assessment of intelligence) {Pershad, 1990} and the Trail Making Test {Horton, 1979}, a pen and paper measure of working memory.

    Changes in cognition from baseline to 21 days intervention, three months and after six months after completing intervention will be assessed.

Secondary Outcomes (1)

  • Symptom assessment General Functioning

    Changes in symptoms from baseline to 21 days intervention, three months and after six months after completing intervention will be assessed.

Other Outcomes (1)

  • Independent Living Skills Survey

    Changes in living skills from baseline to 21 days intervention, three months and after six months after completing intervention will be assessed

Study Arms (3)

Yoga Training Group

EXPERIMENTAL

Yoga Training: Participants will be imparted yoga training for twenty-one days, for one hour a day. This will include postures or Asanas (exercises) and Pranayam (Breathing protocols).

Behavioral: Yoga Training

Treatment as Usual Group

PLACEBO COMPARATOR

Participants who will continue in the department with clinical treatment as usual. No supplementation will be provided

Other: Treatment as Usual

Physical Exercise Group

ACTIVE COMPARATOR

Physical Exercise: This group will take part in a general physical exercise program incorporating simple physical exercises for one hour daily, including Saturdays. The schedule will include fifteen minutes of brisk walking followed by light exercises.

Behavioral: Physical Exercise

Interventions

Yoga TrainingBEHAVIORAL

Participants will be imparted yoga training for twenty-one days, for one hour a day. This will include postures or Asanas (exercises) and Pranayam (Breathing protocols). The training starts with 'Om' chanting followed by warm up exercises and then breathing exercises. The Breathing exercises (Pranayama) are practiced before practice of Asana.

Yoga Training Group

This group will take part in a general physical exercise program incorporating simple physical exercises for one hour daily, including Saturdays. The schedule will include fifteen minutes of brisk walking followed by light exercises adapted from the National Fitness Corps - Handbook for Middle High and Higher Secondary Schools as used by Duraiswamy et al. (2007).

Physical Exercise Group

Placebo Comparator: Treatment as Usual Group Participants who will continue in the department with clinical treatment as usual. No supplementation will be provided

Treatment as Usual Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • DSM IV diagnosis of SZ
  • Age 18 years or greater
  • Residents of Delhi (to facilitate regular attendance and avoid dropouts)

You may not qualify if:

  • Residence outside Delhi
  • Prior participation in our Yoga studies (see preliminary studies section)
  • Mental retardation sufficient to impact understanding of YT
  • Substance or alcohol dependence for last six months which interferes with diagnosis
  • Presence of co-morbid conditions which may worsen with exercises (eg, recent myocardial infarction, fractures)
  • Presence of neurological illnesses such as strokes or head injury that may cause cognitive impairment independent of SZ, or complicates diagnosis/evaluation e.g. epilepsy, stroke
  • Presence of any physical disability or illness which makes the patient unfit for yoga or physical exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Schizophrenia

Interventions

ExerciseTherapeutics

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Triptish Bhatia, PhD

    GRIP-Yoga Study, Dept. of Psychiatry, PGIMER-Dr.R.M.L.Hospital, New Delhi, India

    PRINCIPAL INVESTIGATOR
  • Smita N Deshpande, Ph.D.

    PGIMER-Dr.R.M.L.Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Consultant

Study Record Dates

First Submitted

June 13, 2013

First Posted

June 18, 2013

Study Start

August 1, 2010

Primary Completion

September 1, 2015

Study Completion

July 1, 2016

Last Updated

November 29, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share